APPLICATION OF THE INTERNATIONAL SYSTEM FOR REPORTING SEROUS FLUID CYTOPATHOLOGY 2020 IN THE DIAGNOSIS OF PLEURAL EFFUSION CYTOLOGY

Thị Tuyết Hạnh Ngô, Thị Hiếu Vũ, Cao Đức Huy Phan, Thanh Phượng Huỳnh

Main Article Content

Abstract

Background: Pleural effusion (PE) is a common clinical condition with diverse etiologies, including infections, inflammatory diseases, and malignancies. The increasing number of PE cases in Vietnam highlights the need for a standardized, accurate, and clinically applicable cytological reporting system. Objective: To investigate the cytological characteristics of pleural effusion according to the International System for Reporting Serous Fluid Cytopathology 2020 (TIS 2020) at the Department of Pathology, Pham Ngoc Thach Hospital, and to evaluate its applicability in routine practice. Materials and Methods: A retrospective cross-sectional descriptive study was conducted on pleural effusion cytology specimens collected from January 2024 to August 2024. Cytological slides were independently evaluated by three experienced cytopathologists and classified according to TIS 2020. Results: The median age was 59 years, with a male-to-female ratio of 1.9. Atypical cells were identified in 42.5% of cases. Common cytological features included high cellularity, three-dimensional clusters, papillary formations, large cells with nuclear enlargement, pleomorphism, hyperchromasia, irregular nuclear membranes, coarse or salt-and-pepper chromatin, prominent nucleoli, high nuclear-to-cytoplasmic ratio, tumor necrosis, and abnormal mitotic figures. According to TIS 2020, the distribution was as follows: non-diagnostic (0.8%), negative for malignancy (62.8%), atypia of undetermined significance (6.9%), suspicious for malignancy (14.2%), and malignant (15.3%). Conclusion: The application of TIS 2020 in pleural effusion cytology is feasible and effective, contributing to standardized reporting, improved diagnostic consistency, and better clinical decision-making.

Article Details

References

Kookoolis AS, Puchalski JT, Murphy TE, Araujo KL, Pisani MA. Mortality of Hospitalized Patients with Pleural Effusions. J Pulm Respir Med. 2014;4(3):184.
2. Yang H, Zhu J, Wang P. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study. Medicine (Baltimore). 2023;102(43):e35707.
3. Zhu Y-l, Ren W-h, Wang Q, Jin H-z, Guo Y-y, Lin D-m. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center. Diagn Pathol. 2022 Jul 2:17(11):56.
4. Pergaris A, Stefanou D, Keramari P, Sousouris S, Kavantzas N, Gogas H, Mikou P. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment. Diagnostics (Basel). 2021;11(12).
5. Sun T, Wang M, Wang H. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies. Cancer Cytopathol. 2022;130(12):964-973.
6. Bhanvadia VM, Santwani PM, Vachhani JH. Analysis of diagnostic value of cytological smear method versus cell block method in body fluid cytology: study of 150 cases. Ethiop J Health Sci. 2014;24(2):125-131.
7. Cakir E, Demirag F, Aydin M, Unsal E. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis. Diagn Cytopathol. 2009;37(1):4-10.
8. Huang CC, Michael CW. Cytomorphological features of metastatic squamous cell carcinoma in serous effusions.Cytopathology.2014;25(2):112-119.